The potential impact of antiretroviral treatment regimens on, respectively, weight gain and safe use during pregnancy, are summarized in two ShareSpot blogs from the AETC network. While the findings were presented at AIDS 2020 and were highlighted by HIV.gov during the June virtual edition of the International AIDS Conference, these ShareSpots, by Susa Coffey, provide a succinct recap and "clinical bottom line" conclusions for clinicians.
The blogs include:
- Weight Gain and Metabolic Complications with ART: Data from AIDS 2020
- Safety of Dolutegravir at Conception: Updated Data
Findings will be included in future updates to the National HIV Curriculum